S&P 500

5.304,72

0,70%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Nascent Biotech Inc (QB) (NBIO)
Nascent Biotech Inc (QB) (NBIO) Notícias

NBIO

Nascent Biotech (QB) (NBIO)

Nascent Biotech Inc (QB)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:NBIO

1

Data	Hora	Fonte	Título	Código	Companhia
27/02/2024	15:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:NBIO	Nascent Biotech Inc (QB)
14/02/2024	16:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:NBIO	Nascent Biotech Inc (QB)
19/12/2023	10:00	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:NBIO	Nascent Biotech Inc (QB)
14/08/2023	17:00	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:NBIO	Nascent Biotech Inc (QB)
03/07/2023	18:15	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	USOTC:NBIO	Nascent Biotech Inc (QB)
29/06/2023	13:27	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:NBIO	Nascent Biotech Inc (QB)
29/06/2023	13:26	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:NBIO	Nascent Biotech Inc (QB)
09/06/2023	16:29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:NBIO	Nascent Biotech Inc (QB)
30/05/2023	07:01	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:NBIO	Nascent Biotech Inc (QB)
14/04/2023	14:52	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:NBIO	Nascent Biotech Inc (QB)
10/11/2022	19:10	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:NBIO	Nascent Biotech Inc (QB)
27/09/2022	07:03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:NBIO	Nascent Biotech Inc (QB)
09/09/2022	07:01	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:NBIO	Nascent Biotech Inc (QB)
21/06/2021	07:11	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:NBIO	Nascent Biotech Inc (QB)
08/01/2021	08:01	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:NBIO	Nascent Biotech Inc (QB)
18/12/2020	19:46	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:NBIO	Nascent Biotech Inc (QB)
27/04/2020	17:54	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:NBIO	Nascent Biotech Inc (QB)
24/03/2020	07:06	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:NBIO	Nascent Biotech Inc (QB)
11/03/2020	14:49	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:NBIO	Nascent Biotech Inc (QB)
15/11/2019	19:16	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:NBIO	Nascent Biotech Inc (QB)
11/09/2019	09:53	InvestorsHub NewsWire	Nascent Biotech Receives One Million Dollar Commitment From TRITON FUNDS LP	USOTC:NBIO	Nascent Biotech Inc (QB)
09/10/2013	09:51	OTC Markets	Venue Change	USOTC:NBIO	Nascent Biotech Inc (QB)
09/10/2013	01:00	OTC Markets	Tier Change	USOTC:NBIO	Nascent Biotech Inc (QB)